| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5604635 | International Journal of Cardiology | 2017 | 29 Pages |
Abstract
Administration of drugs targeting mitochondrial function in STEMI patients undergoing primary PCI appear to have no effect on mortality, but may reduce hospital readmission for HF. The drugs with a broad-spectrum mechanism of action seem to be more effective in reducing adverse events.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Gianluca Campo, Rita Pavasini, Giampaolo Morciano, A. Michael Lincoff, C. Michael Gibson, Masafumi Kitakaze, Jacob Lonborg, Amrita Ahluwalia, Hideki Ishii, Michael Frenneaux, Michel Ovize, Marcello Galvani, Dan Atar, Borja Ibanez, Giampaolo Cerisano,